Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review

The antimicrobial drugs currently used for the management of tuberculosis (TB) exhibit poor bioavailability that necessitates prolonged treatment regimens and high dosing frequency to achieve optimal therapeutic outcomes. In addition, these agents cause severe adverse effects, as well as having detr...

Descripción completa

Detalles Bibliográficos
Autores principales: Buya, Aristote B., Witika, Bwalya A., Bapolisi, Alain M., Mwila, Chiluba, Mukubwa, Grady K., Memvanga, Patrick B., Makoni, Pedzisai A., Nkanga, Christian I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708335/
https://www.ncbi.nlm.nih.gov/pubmed/34959323
http://dx.doi.org/10.3390/pharmaceutics13122041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708335/
https://www.ncbi.nlm.nih.gov/pubmed/34959323
http://dx.doi.org/10.3390/pharmaceutics13122041

Ejemplares similares